123 related articles for article (PubMed ID: 3665836)
1. Stabilization, partial purification, and characterization of thyrotropin receptors in solubilized guinea pig fat cell membranes.
Iida Y; Amir SM; Ingbar SH
Endocrinology; 1987 Nov; 121(5):1627-36. PubMed ID: 3665836
[TBL] [Abstract][Full Text] [Related]
2. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
[TBL] [Abstract][Full Text] [Related]
3. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
[TBL] [Abstract][Full Text] [Related]
4. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
[TBL] [Abstract][Full Text] [Related]
5. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
Abe Y
Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
8. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
9. Solubilization, purification, and partial characterization of thyrotropin receptor from bovine and human thyroid glands.
Koizumi Y; Zakarija M; McKenzie JM
Endocrinology; 1982 Apr; 110(4):1381-91. PubMed ID: 6120830
[TBL] [Abstract][Full Text] [Related]
10. Binding of immunoglobulin G from patients with autoimmune thyroid diseases to solubilized guinea pig fat cell membranes crosslinked with 125I-TSH.
Iida Y; Konishi J; Misaki T; Kasagi K; Endo K; Kuma K; Torizuka K
Endocrinol Jpn; 1986 Jun; 33(3):333-43. PubMed ID: 2428605
[TBL] [Abstract][Full Text] [Related]
11. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
[TBL] [Abstract][Full Text] [Related]
12. Design of a long-lived thyrotropin antagonist from derivatives of human chorionic gonadotropin.
Hoermann R; Amir SM; Nomura T; Ingbar SH
Endocrinology; 1989 Jan; 124(1):223-32. PubMed ID: 2462487
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
Loeffler M; Zakarija M; McKenzie JM
J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
[TBL] [Abstract][Full Text] [Related]
14. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.
Hoermann R; Amir SM; Ingbar SH
Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396
[TBL] [Abstract][Full Text] [Related]
15. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
Davies TF; Platzer M
Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
[TBL] [Abstract][Full Text] [Related]
16. Human thyrotropin receptor subunits characterized by thyrotropin affinity purification and western blotting.
Leedman PJ; Newman JD; Harrison LC
J Clin Endocrinol Metab; 1989 Jul; 69(1):134-41. PubMed ID: 2471709
[TBL] [Abstract][Full Text] [Related]
17. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors.
de Bruin TW; van der Heide D
Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495
[TBL] [Abstract][Full Text] [Related]
18. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
19. Properties of thyrotropin (TSH) binding to plasma membranes prepared from rat fat tissues.
Kaise K; Kaise N; Yoshida K; Itagaki Y; Kiso Y; Arai T; Yamamoto M; Sakurada T; Saito S; Yoshinaga K
Tohoku J Exp Med; 1988 Feb; 154(2):115-24. PubMed ID: 3381221
[TBL] [Abstract][Full Text] [Related]
20. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
